國家衛生研究院 NHRI:Item 3990099045/12551
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 911794      線上人數 : 974
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/12551


    題名: Antiviral activity of llama-inspired single domain antibody against Enterovirus A71
    作者: Huang, PN;Wang, HC;Hung, HC;Tseng, SN;Chang, TY;Chou, MY;Chen, YJ;Wang, YM;Shih, SR;Hsu, JT
    貢獻者: Institute of Biotechnology and Pharmaceutical Research
    摘要: In the past few decades, Enterovirus A71 (EVA71) has caused devastating outbreaks in the Asia-Pacific region resulting in serious sequelae in infected young children. No preventive and therapeutic interventions are currently available for curing EVA71 infection, highlighting a great unmet medical need for this disease. Here, we showed that one novel single domain antibody (sdAb, F1) isolated from an immunized llama could alleviate EVA71 infection, both in vitro and in vivo We also confirmed that the sdAb clone F1 recognizes EVA71 through a novel conformational epitope comprising the highly conserved region of VP3 capsid protein by using competitive-binding and overlapping-peptide ELISA assays. Because of the virion's icosahedral structure, we reasoned that adjacent epitopes must be clustered within molecular ranges that may be simultaneously bound by an engineered antibody with multiple valency. Therefore, two single domain binding modules (F1) were fused to generate an sdAb-in-tandem design so that the capture of viral antigens can be further increased by valency effects. We showed that the tetravalent construct, F1xF1-hFc, containing two sdAb-in-tandem on an Fc scaffold, exhibits more potent neutralization activity against EVA71 than the bivalent sdAb, F1-hFc, for at least 5.8-fold. We also demonstrated that, using a human scavenger receptor class B member 2 (hSCARB2) transgenic mouse model, a half-dose of the F1xF1-hFc provided better protection against EVA71 infection than did the F1-hFc. Thus, our study furnishes important insights into multivalent sdAb engineering against viral infection and provides a novel strategic deployment approach for preparedness of emerging infectious diseases such as EVA71.
    日期: 2020-05
    關聯: Antimicrobial Agents and Chemotherapy. 2020 May;64(5):Article number e01922-19.
    Link to: http://dx.doi.org/10.1128/aac.01922-19
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0066-4804&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000528256200024
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85083698721
    顯示於類別:[徐祖安] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    PUB32152074.pdf3173KbAdobe PDF308檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋